23/10/2013 Announcement:CEO Presentation to 2013 AGM clearly states the potential of a capital raising pg21. It also notes cohort four had begun pg6
11/11/2013 Announcement:Patrys to initiate an Investigator-Sponsored Clinical Trial using PAT-SM6 in combination with Onyx Pharmaceuticals’ carfilzomib.
29/11/13 Announcement:Data from Final Cohort of Patients in Multiple Myeloma Clinical Trial
11/12/2013 or perhaps a day or two earlier an interim report with results from Onyx Pharmaceuticals’??? Maybe.
If a successful interim report from Onyx Pharmaceuticals’ trial is published prior to the close of the rights issue I'd suggest someone has given these last few weeks a great deal of consideration.
How many lawyer hours would 12.5 million cover?? Any deal with any company/ies would have three or four jurisdictions to cover
just some scattered thoughts on my part
running out of ammo?, page-2
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $17.34K | 2.497M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 6470626 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1004952 | 2 |
View Market Depth
| Last trade - 15.56pm 23/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |